
Aurevia Poland sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Aurevia Poland is a consulting company that provides services in medtech regulatory compliance and clinical research, supporting pharmaceuticals, advanced therapy medicinal products (ATMPs), biologics, medical devices, and in vitro diagnostic (IVD) devices. They offer full-service clinical research organization (CRO) services and quality assurance and regulatory affairs services throughout the lifecycle of medical devices. Additionally, Aurevia Academy provides professional training in quality assurance, regulatory affairs, and clinical research.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 147 days late).
- 202522/06/2026
- 202424/06/2025
- 202325/06/2024
- 2022filed
- 202109/12/2022
- 202022/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

MD software process design course: 25-26 November
This course is designed for professionals developing or managing medical devices containing software or software as a medical device (SaMD).

European Society for Medical Oncology (ESMO) Congress: 23-27 October
Aurevia will participate in the ESMO Congress 2026, organized by the European Society for Medical Oncology.

Health Design: 28-29 October
We’re attending Health Design in Finland, where we look forward to discussing healthcare innovation, AI, digital health, and improving patient outcomes.

Medical devices for beginners: 20-21 October
Join us for the online seminar called Medical device for beginners (Medizinprodukte für Einsteiger*innen) hosted by FORUM Institut on 20-21 October.
Industry
Offer
- Clinical trials
- Clinical trial management
- Pharmacovigilance
- Medical writing
- Clinical data management
- Biostatistical analysis
- Regulatory consulting
Websites
- aurevia.comAurevia Quality, Regulatory and CRO Consulting ServicesHubSpotGoogle AnalyticsGoogle Tag ManagerCloudflare
Public procurement
1 tender recorded as contractor, with a total value of $292,558.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 8, 2024 | Sponsor support for conducting a non-commercial clinical trial (the so-called CRO service) under the project “Ocena skuteczności i bezpieczeństwa stosowania jodowych środków kontrastowych w mammografii spektralnej w korelacji z badaniem rezonansu magnetycznego piersi u chorych z podejrzeniem raka piersi.” for Uniwersytet Jagielloński – Collegium Medicum w Krakowie. | $292.6K$292,558 | Uniwersytet Jagielloński - Collegium Medicum |
Job offers
The company lists 1 job opening on its own careers page: aurevia.com/careers.
Authorized Representatives
Manner of representation
The President of the Management Board independently; a member of the management board who is not the President of the Management Board jointly with another member of the management board or with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aurevia Oy | 150 | $2,025.93 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-01-15.
83 2490 1057 0000 9900 2307 0073
94 2490 0005 0000 4600 3558 3863
04 2490 0005 0000 4600 4227 9162
Debt
No entries in the National Debtors Register (KRZ).
Public aid
12 public aid cases recorded, with a total value of $248,711.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $43,924$43,924 | Górnośląski Akcelerator Przedsiębiorczości Rynkowej sp. z o.o. | |
| Apr 26, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $493$493 | Prezydent Miasta Tychy | |
| Nov 10, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,473$12,473 | Górnośląski Akcelerator Przedsiębiorczości Rynkowej sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Arcana sp. z o.o. | $2,589,234.56 | inar.pl | ||
| Pure Clinical sp. z o.o. | $1,676,907.27 | pureclinical.eu | ||
| Aslab Science P.S.A. | $1,504,132.17 | aslabsci.com | ||
| Centrum Innowacji Grabowski sp. k. | $1,184,214.10 | centruminnowacji.pl | ||
| TAK Pharma sp. z o.o. | $1,137,298.16 | takpharma.com | ||
| Bioresearch Group sp. z o.o. | $776,186.19 | bioresearch.pl | ||
| GJ Pharma sp. z o.o. | $551,137.15 | gjpharma.pl | ||
| Pharmalogics sp. z o.o. | $540,258.50 | pharmalogics.pl | ||
| Centrum Hta sp. z o.o. | $479,257.12 | centrumhta.com | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-01-10 | Name change (Clinical Consulting → Aurevia Poland) | |
| 2023-10-23 | PKD change (Removed: 9 codes; Added: 5 codes) | |
| 2021-01-21 | PKD change (Removed: 5 codes; Added: 10 codes) | |
| 2018-09-27 | Share capital increase (5,000.00 PLN → 7,500.00 PLN) | |
| 2015-08-01 | Business resumed |
FAQ
Last updated: 2026-10-07